Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia
Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
30 Mar 2017
|
| In: |
Molecular & cellular oncology
Year: 2017, Volume: 4, Issue: 2, Pages: 1-3 |
| ISSN: | 2372-3556 |
| DOI: | 10.1080/23723556.2017.1291396 |
| Online Access: | Verlag, Volltext: https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396 Resolving-System, Volltext: https://dx.doi.org/10.1080/23723556.2017.1291396 |
| Author Notes: | Stefanie Göllner and Carsten Müller-Tidow |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1019406259 | ||
| 003 | DE-627 | ||
| 005 | 20230428065406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180424s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/23723556.2017.1291396 |2 doi | |
| 035 | |a (DE-627)1019406259 | ||
| 035 | |a (DE-599)GBV1019406259 | ||
| 035 | |a (OCoLC)1340370535 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Göllner, Stefanie |d 1979- |e VerfasserIn |0 (DE-588)133882764 |0 (DE-627)557870151 |0 (DE-576)300169191 |4 aut | |
| 245 | 1 | 0 | |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia |c Stefanie Göllner and Carsten Müller-Tidow |
| 264 | 1 | |c 30 Mar 2017 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome | ||
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular & cellular oncology |d London : Taylor & Francis, 2014 |g 4(2017), 2, Artikel-ID e1291396, Seite 1-3 |h Online-Ressource |w (DE-627)835890988 |w (DE-600)2835425-4 |w (DE-576)44572093X |x 2372-3556 |7 nnas |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia |
| 773 | 1 | 8 | |g volume:4 |g year:2017 |g number:2 |g elocationid:e1291396 |g pages:1-3 |g extent:3 |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia |
| 856 | 4 | 0 | |u https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396 |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1080/23723556.2017.1291396 |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200302 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 133882764 |a Göllner, Stefanie |m 133882764:Göllner, Stefanie |d 910000 |d 910100 |e 910000PG133882764 |e 910100PG133882764 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1019406259 |e 3601534134 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","given":"Stefanie","display":"Göllner, Stefanie","family":"Göllner"},{"given":"Carsten","role":"aut","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"}],"title":[{"title_sort":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia","title":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"30 Mar 2017"}],"id":{"eki":["1019406259"],"doi":["10.1080/23723556.2017.1291396"]},"relHost":[{"id":{"issn":["2372-3556"],"zdb":["2835425-4"],"eki":["835890988"]},"recId":"835890988","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemiaMolecular & cellular oncology","note":["Gesehen am 21.09.2024"],"origin":[{"publisher":"Taylor & Francis","dateIssuedKey":"2014","dateIssuedDisp":"2014-","publisherPlace":"London"}],"pubHistory":["1.2014 -"],"title":[{"title":"Molecular & cellular oncology","title_sort":"Molecular & cellular oncology"}],"part":{"pages":"1-3","year":"2017","text":"4(2017), 2, Artikel-ID e1291396, Seite 1-3","issue":"2","extent":"3","volume":"4"},"titleAlt":[{"title":"Molecular and cellular oncology"}],"language":["eng"]}],"recId":"1019406259","physDesc":[{"extent":"3 S."}],"language":["eng"],"name":{"displayForm":["Stefanie Göllner and Carsten Müller-Tidow"]}} | ||
| SRT | |a GOELLNERSTINHIBITION3020 | ||